Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia
Clinical trial NCT04519567 · COMPLETED
Trial details
- NCT number
- NCT04519567
- Sponsor
- Larimar Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-31
- Primary completion
- 2021-03-16
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.